卖什么
AI and Data for Cancer Therapeutics
商业模式拆解
买家：谁掌握预算？
未核实Drug-discovery and gene-therapy R&D teams at biotech/pharma.
工作流：什么输入变成什么输出？
Axis model generates regulatory DNA elements and predicts their function, aimed at safer gene and cell therapies; a data engine over predicted cell data.
渠道：怎么接触到客户？
Gated access: "Get Access" button; no pricing shown.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| 2026-10-16 | — | $20M | Accel (lead), Zacua Ventures (lead) | news.google.com |
| 2026-10-16 | — | $20M | — | news.google.com |
| 2026-10-15 | — | $20M | Accel, Zacua | news.google.com |
| 2026-10-15 | — | $20M | — | news.google.com |
| 2026-10-15 | — | $20M | — | news.google.com |
| — | YC 2026 冬季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-17.